| 6776- | TQ, | Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects |
| - | Review, | Nor, | NA |
| 7936- | TQ, | Effect of Nigella sativa supplementation on lung function and inflammatory mediators in partly controlled asthma: a randomized controlled trial |
| - | Trial, | Asthma, | NA |
| 7935- | TQ, | Nigella sativa Supplementation Improves Asthma Control and Biomarkers: A Randomized, Double-Blind, Placebo-Controlled Trial |
| - | Trial, | Asthma, | NA |
| 7937- | TQ, | Effectiveness of thymoquinone in the treatment of experimental asthma |
| - | in-vivo, | Asthma, | NA |
| 7938- | TQ, | The effect of single dose of thymoquinone, the main constituents of Nigella sativa, in guinea pig model of asthma |
| - | in-vivo, | Asthma, | NA |
| 7939- | TQ, | Effects of Nigella sativa and its constituents on inflammatory markers in ovalbumin-induced asthma model: a preclinical systematic review and meta-analysis |
| - | Review, | Asthma, | NA |
| 7940- | TQ, | Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation |
| - | in-vivo, | Asthma, | NA |
| 7941- | TQ, | Downregulation of leukotriene biosynthesis by thymoquinone attenuates airway inflammation in a mouse model of allergic asthma |
| - | in-vivo, | Asthma, | NA |
| 7942- | TQ, | Thymoquinone inhibits inflammation, neoangiogenesis and vascular remodeling in asthma mice |
| - | in-vitro, | Asthma, | NA |
| 5024- | TQ, | Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients? |
| - | Review, | Covid, | NA |
| 4565- | TQ, | Thymoquinone in the clinical treatment of cancer: Fact or fiction? |
| - | Review, | BC, | NA |
| 4538- | TQ, | Thymoquinone Anticancer Effects Through the Upregulation of NRF2 and the Downregulation of PD‐L1 in MDA‐MB‐231 Triple‐Negative Breast Cancer Cells |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-468 |
| 2454- | Trip, | Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ |
| - | in-vitro, | HNSCC, | HaCaT | - | in-vivo, | NA, | NA |
| 7404- | Trip, | Potential of traditional ayurvedic formulation, Triphala, as a novel anticancer drug |
| - | in-vitro, | BC, | MCF7 |
| 7405- | Trip, | Cytotoxic response of breast cancer cell lines, MCF 7 and T 47 D to triphala and its modification by antioxidants |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | T47D |
| 3747- | TTT, | Tumor treating induced fields: a new treatment option for patients with glioblastoma |
| - | in-vitro, | GBM, | U87MG |
| 2412- | TTT, | A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights |
| - | Review, | GBM, | NA |
| 2413- | TTT, | Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [18F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression |
| - | in-vitro, | GBM, | U87MG |
| 6456- | TUR, | Ar-turmerone inhibits the proliferation and mobility of glioma by downregulating cathepsin B |
| - | in-vitro, | GBM, | U251 | - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | LN229 |
| 6452- | TUR, | Turmeric Essential Oil Constituents as Potential Drug Candidates: A Comprehensive Overview of Their Individual Bioactivities |
| - | Review, | Nor, | NA |
| 6453- | TUR, | Pharmacological Profile, Bioactivities, and Safety of Turmeric Oil |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
| 6454- | TUR, | Selective induction of apoptosis by ar-turmerone isolated from turmeric (Curcuma longa L) in two human leukemia cell lines, but not in human stomach cancer cell line |
| - | in-vitro, | AML, | HL-60 | - | in-vitro, | GC, | NA |
| 6460- | TUR, | CUR, | Neuroprotective Effect of Turmeric Extract in Combination with Its Essential Oil and Enhanced Brain Bioavailability in an Animal Model |
| - | in-vivo, | AD, | NA |
| 6459- | TUR, | Curcumin combined with turmerones, essential oil components of turmeric, abolishes inflammation-associated mouse colon carcinogenesis |
| - | in-vivo, | Nor, | NA | - | in-vivo, | Colon, | NA |
| - | in-vitro, | lymphoma, | U937 |
| 6457- | TUR, | The Role of Turmerones on Curcumin Transportation and P-Glycoprotein Activities in Intestinal Caco-2 Cells |
| - | in-vitro, | Colon, | Caco-2 |
| 6455- | TUR, | Induction of apoptosis by ar-turmerone on various cell lines |
| - | in-vitro, | AML, | K562 | - | in-vitro, | lymphoma, | U937 |
| 5904- | TV, | Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development |
| - | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | Diabetic, | NA | - | Review, | Obesity, | NA | - | Review, | AD, | NA | - | Review, | Arthritis, | NA |
| 5934- | TV, | Protective Effects of Natural Antioxidants on Inflammatory Bowel Disease: Thymol and Its Pharmacological Properties |
| - | Review, | Var, | NA |
| 5911- | TV, | Thymol Isolated from Thymus vulgaris L. Inhibits Colorectal Cancer Cell Growth and Metastasis by Suppressing the Wnt/β-Catenin Pathway |
| - | vitro+vivo, | CRC, | NA |
| 5935- | TV, | CAR, | Effects of thymol and carvacrol supplementation on intestinal integrity and immune responses of broiler chickens challenged with Clostridium perfringens |
| - | in-vivo, | Nor, | NA |
| 1139- | UA, | Ursolic acid inhibits epithelial-mesenchymal transition by suppressing the expression of astrocyte-elevated gene-1 in human nonsmall cell lung cancer A549 cells |
| - | in-vitro, | Lung, | A549 |
| 1058- | UA, | Ursolic acid, an antagonist for transforming growth factor (TGF)-beta1 |
| - | in-vivo, | NA, | NA |
| 1020- | UA, | Root Bark of Morus alba L. and Its Bioactive Ingredient, Ursolic Acid, Suppress the Proliferation of Multiple Myeloma Cells by Inhibiting Wnt/β-Catenin Pathway |
| - | in-vitro, | Melanoma, | RPMI-8226 |
| 119- | UA, | CUR, | RES, | Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | PC3 |
| 942- | UA, | Ursolic Acid Inhibits Breast Cancer Metastasis by Suppressing Glycolytic Metabolism via Activating SP1/Caveolin-1 Signaling |
| - | vitro+vivo, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 5017- | UA, | Ursolic acid disturbs ROS homeostasis and regulates survival-associated gene expression to induce apoptosis in intestinal cancer cells |
| - | in-vitro, | Cerv, | INT-407 | - | in-vitro, | CRC, | HCT116 |
| 5018- | UA, | Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studies |
| - | Review, | Var, | NA |
| 5019- | UA, | Ursolic acid in colorectal cancer: mechanisms, current status, challenges, and future research directions |
| - | Review, | Var, | NA |
| 5020- | UA, | Anticancer activity of ursolic acid on human ovarian cancer cells via ROS and MMP mediated apoptosis, cell cycle arrest and downregulation of PI3K/AKT pathway |
| - | in-vitro, | Ovarian, | NA |
| 5021- | UA, | Anticancer effect of ursolic acid via mitochondria-dependent pathways |
| - | Review, | Var, | NA |
| 5022- | UA, | Ursolic Acid’s Alluring Journey: One Triterpenoid vs. Cancer Hallmarks |
| - | Review, | Var, | NA |
| 5023- | UA, | CA, | RosA, | Therapeutic Effect of Rosemary and Its Active Constituent on Nervous System Disorders |
| - | Review, | Park, | NA | - | Review, | AD, | NA |
| 1310- | UA, | Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells |
| - | in-vitro, | BC, | MCF7 |
| 2411- | UA, | Ursolic acid in health and disease |
| - | Review, | Var, | NA |
| 2350- | UA, | Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 8439- | UA, | OM, | Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase |
| - | Study, | AD, | NA |
| 3788- | UA, | RosA, | Ursolic acid and rosmarinic acid ameliorate alterations in hippocampal neurogenesis and social memory induced by amyloid beta in mouse model of Alzheimer’s disease |
| - | in-vivo, | AD, | NA |
| 3789- | UA, | Ex, | Combined Ursolic Acid and Resistance/Endurance Training Improve Type 3 Diabetes Biomarkers-Related Memory Deficits in Hippocampus of Aged Male Wistar Rats |
| - | in-vivo, | AD, | NA |
| 3790- | UA, | Therapeutic applications of ursolic acid: a comprehensive review and utilization of predictive tools |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid